Tafecta is the 1st global generic of Tenofovir Alafenamide. Tenofovir Alafenamide is an oral nucleoside reverse transcriptase inhibitor (NRTIs).Itis indicated for the treatment of chronic hepatitis b virus (HBV) infection in adults with compensated liver disease.
Indication and Usage: Tafecta is a hepatitis B virus (HBV) nucleoside analog reverse transcriptase inhibitor and is indicated for the treatment of chronic hepatitis B virus infection in adults with compensated liver disease.
|Product Name||: Tafecta|
|Generic Name||:Tenofovir Alafenamide|
|Formulation||:Solid dosage form(Tablet)|
|Available size||: 3×10’s|
Categories: Anti-Viral, Biotech Product, Drugs to Treat Hepatitis